You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Tumor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w)

Not yet recruiting
  • Hepatocellular Carcinoma
  • ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w
  • (no location specified)
Jun 28, 2022

Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 18, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Advanced Malignant Cancer Trial (SHR-2022 Injection)

Not yet recruiting
  • Advanced Malignant Cancer
  • SHR-2022 Injection
  • (no location specified)
Nov 8, 2023

Advanced Malignant Tumors Trial (NBL-020 for Injection)

Not yet recruiting
  • Advanced Malignant Tumors
  • NBL-020 for Injection
  • (no location specified)
May 18, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Advanced Solid Tumor Trial in Shanghai (SY-4798)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai East Hospital
Aug 10, 2022

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)

Recruiting
  • HER2-positive Breast Cancer
  • Operable Breast Cancer
  • Avignon, France
  • +8 more
Jan 9, 2023

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

Not yet recruiting
  • Locally Advanced Urothelial Carcinoma
  • +3 more
  • (no location specified)
Sep 15, 2022

Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

Not yet recruiting
  • Stage IIIA Hepatocellular Carcinoma
  • Radiotherapy combined with TKI and Anti-PD-1 Antibody
  • (no location specified)
Sep 24, 2023

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Lung Cancer Trial (ortataxel)

Completed
  • Lung Cancer
  • (no location specified)
Sep 23, 2022

Oncology Trial (IMM27M)

Not yet recruiting
  • Oncology
  • (no location specified)
Feb 10, 2022

Metastatic Castration Resistant Prostate Cancer Trial in New York, Pittsburgh, Seoul (DZD2269)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • New York, New York
  • +5 more
Jul 6, 2022

HER2-positive Advanced Solid Tumor Trial in Zigong (ZV0203)

Enrolling by invitation
  • HER2-positive Advanced Solid Tumor
  • Zigong, Shandong, China
    PKUCare Luzhong Hospital
Jun 14, 2022

NSCLC Trial in Shanghai (IN10018, Furmonertinib)

Recruiting
  • NSCLC
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Australia (HP518 - Dose Escalation, HP518 - Dose expansion)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 - Dose expansion
  • Albury, New South Wales, Australia
  • +4 more
May 5, 2022

Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)

Recruiting
  • Metastatic Breast Cancer
  • Ixabepilone Injection
  • Aalst, Belgium
  • +11 more
Nov 28, 2022

Oral Squamous Cell Carcinoma Trial (PRV211 (Intraoperative Cisplatin System))

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • PRV211 (Intraoperative Cisplatin System)
  • (no location specified)
May 30, 2023

Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Perth, Western Australia, Australia
    Linear Clinical Research Ltd
Apr 20, 2023